Advanced Gastric Cancer Clinical Trials

92 clinical trials for Advanced Gastric Cancer across international registries, including 13 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• Phase 1/2 Study of BHB810 in Advanced Gastric and GEJ Adenocarcinoma — RECRUITING · PHASE1
• Safety and Efficacy of Leucine-Restricted Diet Combined With Chemotherapy and Immunotherapy in Advanced Gastric Cancer — RECRUITING · PHASE2
• PD1/TGFβ In Combination With SHR2554 or Apatinib And Chemotherapy For First - Line Treatment Of Gastric Cancer — RECRUITING · PHASE2
• Clinical Trial on the Safety, Tolerance and Preliminary Efficacy of XH001 Injection Combined With Neoantigen Vaccine-induced Tumor-specific T-cell Injection in Advanced Gastric Cancer — RECRUITING · PHASE1
• Evaluation of the Effectiveness of Managing Chemotherapy Side Effects Using ePRO and a Standardized Telenursing Program for Cancer Patients — RECRUITING · NA
• Iparomlimab and Tuvonralimab (QL1706) Combined With Chemotherapy for Previously Untreated Advanced or Metastatic Gastric or Gastroesophageal Junction Cancer — RECRUITING · PHASE2
• Optimal Methods to Characterize ADC Resistance in Solid Tumors and Identify Clinically Useful Biomarkers — RECRUITING · PHASE2
• Safety and Efficacy of SHR2554 Combined With Other Antitumor Therapies in Gastric or Gastro-oesophageal Junction Adenocarcinoma — RECRUITING · PHASE2
• HS-10502 Combination Treatment in Patients With Advanced Solid Tumors — RECRUITING · PHASE1
• Fecal Microbiota Transplantation (FMT) in Patients With Advanced Gastric Cancer — RECRUITING · NA
• A Multi-center Real-world Efficacy and Safety of Trastuzumab-deruxtecan in Advanced Gastric Cancer — RECRUITING
• Zolbetuximab Claudin18.2 Positive, HER2 Negative, Advanced Gastric Cancer — RECRUITING
• First-Line and Neoadjuvant Immunotherapy for Gastric Cancer — RECRUITING
• A randomized, double-blind, multi-center phase III study comparing everolimus (RAD001) plus best supportive care versus placebo plus best supportive care in patients with advanced gastric cancer after progression on prior systemic chemotherapy — COMPLETED · PHASE3
• Local and systemic immune modulation by Rilvegostomig (AZD2936) in the treatment of advanced gastric cancer (RILVE Project) — NOT_YET_RECRUITING · PHASE2
• A Study of Disitamab Vedotin With Other Anticancer Drugs in Solid Tumors — ACTIVE_NOT_RECRUITING · PHASE2
• A First-in-human Study of BGB-53038, a Pan-KRAS Inhibitor, Alone or in Combinations in Participants With Advanced or Metastatic Solid Tumors With KRAS Mutations or Amplification — TERMINATED · PHASE1
• Evaluation of Pressurized Intraperitoneal Aerosol Chemotherapy With VRT106 Versus PIPAC in Patients With Advanced Gastric Cancer and PeritonealMetastasis: A Prospective, Multicenter, Open-Label, Randomized Controlled Trial — NOT_YET_RECRUITING · PHASE2
• A Prospective, Single-arm, Exploratory Study of Trifluridine/Tipiracil (TAS-102) Combined With Apatinib as Third-line Therapy for Advanced Gastric Cancer — NOT_YET_RECRUITING · NA
• [18F]FAPI-PET/CT and Laparoscopy in STagIng advanced gastric Cancer – a multicenter prospective study (PLASTIC-3-study) — TERMINATED · PHASE3
• A Phase III Study of Fruquintinib in Combination With Paclitaxel in Second Line Gastric Cancer(FRUTIGA) — COMPLETED · PHASE3
• MAIC of Fruquintinib Plus Paclitaxel Versus Ramucirumab Plus Paclitaxel in Advanced G/GEJ Adenocarcinoma — NOT_YET_RECRUITING
• SBRT-LDRT-Cadonilimab for Advanced Gastric, Colorectal and Ovarian Cancers With Peritoneal Metastases — ACTIVE_NOT_RECRUITING · PHASE1
• Potential Advantages of Robotic Total Gastrectomy in Advanced Middle-Upper Gastric Cancer: A Multicenter Propensity Score Matching Analysis — COMPLETED
• Perioperative mFOLFOX-6 in Locally Advanced Gastric Cancer — COMPLETED · PHASE2
• Lenvatinib and Pembrolizumab Simultaneous Combination Study — COMPLETED · PHASE2
• Camrelizumab Combined with Apatinib Mesylate Tablets, Nab-paclitaxel and S-1 in the Treatment of Locally Advanced Gastric Cancer — COMPLETED · PHASE2
• A Single-arm, Single-center Phase II Clinical Study on the Clinical Efficacy and Safety of Paclitaxel Polymeric Micelles for Injection Combined With Fruquintinib Capsules in the Second-line Treatment of Patients With Advanced Gastric Cancer — NOT_YET_RECRUITING · PHASE2
• IMM2902, a HER2/SIRPα Bispecific MAb-Trap Antibody-receptor Fusion Protein, in Patients with HER2-expressing Advanced Solid Tumors — SUSPENDED · PHASE1
• The Combination of Adebrelimab, Apatinib, and Lrinotecan Liposome for Second-line Treatment of Advanced Gastric Cancer — NOT_YET_RECRUITING · PHASE1
• Liposomal Irinotecan Combination Regimen for Second-line Treatment of Advanced Gastric Cancer — OTHER · NA
• Neoantigen Reactive T Cells c for Chinese Patients With Advanced Gastric Cancer — NOT_YET_RECRUITING · PHASE1
• A Phase II Study of TACE Plus PD-1 Antibody in the Locally Advanced Stomach Adenocarcinoma — OTHER · PHASE2
• Biomarker-oriented Study of Durvalumab (MEDI4736) in Combination With Olaparib and Paclitaxel in Gastric Cancer — OTHER · PHASE2
• Neoadjuvant Treatment Based on Gastric Cancer Molecular Subtyping. — COMPLETED
• IMC001 for Clinical Research on Advanced Digestive System Malignancies — OTHER · PHASE1
• Ramucirumab Combined With Nab-paclitaxel, Lobaplatin, and S-1 in Neoadjuvant Transformation Therapy for Advanced Gastric Cancer — OTHER · PHASE4
• A Study to Test Combination Treatments in Participants With Advanced Gastric Cancer — COMPLETED · PHASE2
• Real-world Study of HER2-overexpressed Advanced Solid Tumors After Progression of First-line Standard Therapy — OTHER
• A Randomized Controlled Trial of Integrated Early Palliative Care for Advanced Gastric Cancer Patients — OTHER · NA
• Tislelizumab Combined With S-1 Plus Oxaliplatin as a Neoadjuvant Treatment in Patients With GC/GEJC — OTHER · PHASE2
• A Phase II Study of Conversion Surgery After IP Paclitaxel With XELOX Chemotherapy in AGC With Peritoneal Dissemination — OTHER · PHASE2
• Study of Antibody Drug Conjugate in Patients With Advanced Breast Cancer Expressing HER2 — COMPLETED · PHASE1
• Phase II Trial of AUY922 vs. Comparators in Advanced Gastric Cancer — COMPLETED · PHASE2
• Phase II of AUY922 in Second-line Gastric Cancer in Combination With Trastuzumab in HER2 Positive Patients — TERMINATED · PHASE2
• Study of Activated Cytokine-induced Killer Armed With Bispecific Antibody for Advanced Gastric Cancer — WITHDRAWN · PHASE2
• Study on the Safety and Effectiveness of UCB-NK Cell Infusion in the Treatment of Advanced Gastric Cancer and Gastroesophageal Cancer — OTHER · NA
• Clinical Study of Albumin-paclitaxel Combined With Apatinib and Camrelizumab in Advanced Gastric Cancer — OTHER · PHASE1
• A Randomized, Double Blind Study Evaluating Paclitaxel With and Without RAD001 in Patients With Gastric Carcinoma After Prior Chemotherapy — COMPLETED · PHASE3
• Capecitabine and Cisplatin (XP)+Sorafenib in Advanced Gastric Cancer (AGC): Sorafenib+XP — COMPLETED · PHASE1

Refine this search